GlassScriptPhysician profile
David Buck
NPI 1841507886
$8,700.65
in general payments reported to CMS, 2019-2025
41 companies · $916 in 2025
The $916 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,110 · 2020: $512 · 2021: $1,483 · 2022: $1,373 · 2023: $1,710 · 2024: $1,597 · 2025: $916.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,219 · Education: $3.20.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,219.13 |
| Education | $3.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heartflow, INC. | $1,716.38 | 2019-2024 | Ffrct |
| Boston Scientific Corporation | $938.63 | 2019-2025 | Emblem Mri S-Icd, Watchman Flx, Watchman Access System |
| Abbott Laboratories | $555.23 | 2019-2025 | Mitraclip, Jot Dx, Amplatzer Amulet |
| Amgen INC. | $520.63 | 2019-2025 | Repatha, Repatha |
| Novartis Pharmaceuticals Corporation | $436.98 | 2019-2025 | |
| Pfizer INC. | $408.92 | 2022-2025 | |
| Cvrx, INC. | $396.01 | 2022-2025 | Barostim Neo System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $343.64 | 2019-2025 | Lifevest |
| Philips North America LLC | $334.26 | 2022-2025 | (Ck7) Extended Holter, (Ck4) Mcot, Ecc Solutions |
| Boehringer Ingelheim Pharmaceuticals, INC. | $301.04 | 2021-2025 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $271.86 | 2019-2024 | Farxiga |
| Biosense Webster, INC. | $233.86 | 2022-2025 | Nuvision Ice Catheter, Carto 3, Octaray Mapping Catheter |
| Inari Medical, INC. | $232.59 | 2023-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Merck Sharp & Dohme LLC | $229.11 | 2021-2023 | Verquvo |
| Sanofi-Aventis U.S. LLC | $190.61 | 2019-2023 |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $166.76 | 2019-2024 | Xarelto |
| Nuwellis, INC. | $159.66 | 2023 | Aquadex Smartflow Console |
| Abiomed | $146.00 | 2023-2024 | Impella |
| Regeneron Healthcare Solutions, INC. | $111.29 | 2019-2025 | Evkeeza |
| Medtronic Vascular, INC. | $108.23 | 2019 | |
| Livanova USA, INC. | $102.95 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $93.78 | 2022-2025 | Eliquis, Camzyos |
| Biotronik INC. | $93.15 | 2019-2021 | |
| Kestra Medical Technology Services, INC. | $68.25 | 2024 | Assure Wcd |
| Novo Nordisk INC | $67.80 | 2023 | Ozempic, Rybelsus |
| Kowa Pharmaceuticals America, INC. | $66.24 | 2020-2022 | |
| Alnylam Pharmaceuticals INC. | $65.76 | 2023-2025 | Onpattro |
| Preventice Services, LLC | $48.64 | 2021 | |
| Arineta, INC | $37.47 | 2021 | |
| Braemar Manufacturing, LLC | $37.15 | 2019 | |
| Portola Pharmaceuticals, LLC | $28.77 | 2020 | |
| Stryker Corporation | $28.62 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Medtronic, INC. | $21.36 | 2021 | |
| Lexicon Pharmaceuticals, INC. | $21.13 | 2024 | |
| Cleerly, INC. | $20.69 | 2024 | Cleerly Ischemia, Cleerly Labs |
| Irhythm Technologies, INC. | $18.25 | 2024 | Zio Monitor, Zio Xt Patch |
| Elutia, INC. | $18.19 | 2024 | Ecm Patch,Pouch |
| Bayer Healthcare Pharmaceuticals INC. | $17.00 | 2021 | |
| Esperion Therapeutics, INC. | $16.72 | 2021 | |
| Ge Healthcare | $15.25 | 2021 | |
| G Medical Diagnostic Services, INC. | $11.79 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Buck listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.